Combinatorial Treatment of Glioblastoma with Temozolomide (TMZ) Plus 5-Ethynyl-2'-deoxyuridine (EdU)
Humeyra Kaanoglu, Yasemin Kübra Akyel, Adebimpe Adefolaju, Alain Valdivia, Dominique M. O. Higgins, Rani S. Sellers, Caroline Mosely, Corey J. Haswell, William C. Zamboni, Shawn Hingtgen, Andrew Satterlee, Aziz Sancar
This study evaluates the combination of TMZ and EdU in treating GBM, showing improved antitumor efficacy in vitro and in preclinical models.
Proceedings of the National Academy of Sciences · Dec 31, 2025Peer-reviewedCancer Biology